Semaglutide Weight Loss: Results and Timeline Explained
Semaglutide is the drug inside both Ozempic and Wegovy, and its weight loss evidence is among the most studied in modern medicine. This page sets out the STEP 1 result, a realistic timeline for how results build, and an honest answer to the question of how much you personally will lose. It is education only, not medical advice.
Semaglutide for weight loss: two labels, one drug
Semaglutide is a GLP-1 receptor agonist taken as a once weekly injection. It reaches the market under two labels that divide its jobs. Ozempic is approved for type 2 diabetes, with doses up to 2 mg once weekly. Wegovy is approved for chronic weight management, with a maintenance dose of 2.4 mg once weekly, or 1.7 mg if 2.4 mg is not tolerated. Wegovy is also approved for adolescents aged 12 and older, and to reduce cardiovascular risk in adults with cardiovascular disease and obesity or overweight. When people search for semaglutide for weight loss, the evidence they are really asking about is the Wegovy evidence, generated at the weight management dose.
The drug works on appetite from two directions. It reduces hunger signals, so people feel satisfied with less, and it slows stomach emptying, so meals stay satisfying for longer. Most people describe the change as food becoming quieter: smaller portions feel complete, and the background urge to snack fades. Weight loss follows from eating less over a long period, which is why dose and duration dominate the results.
The STEP 1 result, with its context attached
STEP 1 is the trial that anchors semaglutide weight loss. Adults taking semaglutide 2.4 mg, with support to reduce calories and increase activity, lost an average of 14.9 percent of their body weight at 68 weeks. Three qualifiers belong with that figure wherever it travels. It was measured at the 2.4 mg Wegovy maintenance dose, not at diabetes doses. It took 68 weeks, which is roughly 16 months of treatment. And it is an average across a large group whose individual results spread widely in both directions.
Translated by simple arithmetic, 14.9 percent of a 100 kilogram starting weight is about 15 kilograms, and of a 90 kilogram start is about 13 kilograms. Those translations describe the group average at different starting weights. They do not sort individuals, and the rest of this page is about the two things that determine where a given person lands: time, and variation.
Semaglutide results timeline
A realistic timeline has three phases. The first phase is titration, roughly the first four to five months on the Wegovy schedule, when the dose climbs through 0.25 mg, 0.5 mg, 1 mg and 1.7 mg steps, each lasting at least four weeks. Doses in this phase are deliberately small, side effects are the main event for many people, and weight change is usually modest. Appetite changes often appear here first, ahead of the scale. Judging semaglutide by this phase alone badly underestimates it.
The second phase is the long maintenance stretch at 2.4 mg, or at 1.7 mg if that is the tolerated dose, where most of the trial average accumulated. Loss in this phase is gradual and uneven, with plateaus lasting weeks that then give way to further progress without any obvious change in behavior. The third phase is the long run: the STEP 1 endpoint at 68 weeks simply marks where the trial stopped measuring, and prescribers think in terms of ongoing treatment, because the stopping studies show regain when the drug is withdrawn. Spread evenly as arithmetic, the trial total is a rough average of a little under 1 percent of starting weight per month. That average is a picture of scale, not a schedule your body will follow month by month.
How much weight will I lose on semaglutide
This is the most natural question and the one no honest source can answer for an individual. Trials report what happened to groups. Your result will be shaped by the dose you reach and how long you stay on it, by your starting weight, since percentages scale with it, by how your eating patterns change in practice, by activity and sleep, by other conditions and medicines, and by simple biological variation that researchers cannot yet predict in advance. Two people can follow the same schedule faithfully and finish far apart, and both outcomes are within the normal spread the trials recorded.
A more useful framing is a range of scenarios rather than a point prediction. If your experience tracks the trial average at full dose for a similar period, the STEP 1 percentage gives the scale. If side effects hold you at a lower dose, or treatment is interrupted, expect proportionally less. If you are taking semaglutide at diabetes doses under the Ozempic label, expect the weight effect to be a secondary benefit rather than the main event. Your prescriber, reviewing your own trend over months, is the only source of a genuinely personal estimate, and even that is a trend, not a guarantee.
The oral form, briefly
Semaglutide also exists as a daily tablet, Rybelsus, approved for type 2 diabetes rather than weight management. The tablet has strict taking rules from its label: it is taken on an empty stomach with a small amount of water, waiting at least 30 minutes before food, drink or other medicines. People sometimes ask whether the tablet is an easier route to the injection results, but the weight loss evidence base belongs to the weekly injection at weight management dosing, and the two forms should not be treated as interchangeable. Your prescriber can explain which form, if any, fits your situation.
Staying safe and keeping the result
Semaglutide carries the class boxed warning about thyroid C cell tumors and should not be used by people with a personal or family history of medullary thyroid carcinoma or with MEN 2. Common effects are gastrointestinal, concentrated around dose increases, and the labels advise stopping semaglutide at least 2 months before a planned pregnancy. While losing weight, protecting muscle with adequate protein and some resistance activity improves the quality of the loss, and the eating guides on this site cover the practical side.
Finally, plan for the stopping question before it arrives. In the STEP 1 extension, people regained about two thirds of the lost weight within a year of stopping semaglutide, as appetite returned to its previous pattern. That finding is why weight management with semaglutide is usually framed as long term treatment. If cost, side effects or personal preference point toward stopping, a planned conversation with your prescriber about maintenance habits and monitoring beats an abrupt end.
Frequently asked questions
How much weight will I lose on semaglutide?
No one can predict an individual result. The group evidence is STEP 1, where adults on semaglutide 2.4 mg lost an average of 14.9 percent of body weight at 68 weeks. Your own result depends on the dose you reach, how long you stay on it, your starting weight, your eating and activity patterns, and biological variation, and it can land well above or below that average.
What is the semaglutide results timeline?
Think in three phases. Titration takes roughly the first four to five months, with doses stepping up at least four weeks apart and modest early loss. The maintenance phase at 2.4 mg, or 1.7 mg if that is tolerated, is where most loss accumulates, unevenly and with plateaus. The STEP 1 measurement point was 68 weeks, and treatment is usually planned as long term after that.
Is semaglutide for weight loss the same as Ozempic?
It is the same drug at different doses under different labels. Ozempic is the diabetes label, up to 2 mg weekly. The weight management label is Wegovy, with a 2.4 mg maintenance dose, and the STEP 1 weight evidence was generated at that dose. Results quoted for weight loss should not be assumed to apply at diabetes doses.
How fast is semaglutide weight loss per month?
Spread evenly as simple arithmetic, the STEP 1 total of 14.9 percent over 68 weeks works out to a rough average of a little under 1 percent of starting weight per month. Real progress is not even: slower during titration, steadier at maintenance, and interrupted by plateaus, so monthly figures will vary a lot around that rough average.
What happens when semaglutide is stopped?
Appetite returns toward its pre treatment pattern and regain is common. In the STEP 1 extension study, participants regained about two thirds of the lost weight within a year of stopping. Prescribers therefore usually discuss long term treatment, or a maintenance plan, from the beginning rather than treating semaglutide as a short course.
Is the semaglutide tablet as effective for weight loss?
The tablet form, Rybelsus, is approved for type 2 diabetes, not weight management, and it follows strict label rules, taken on an empty stomach with a small amount of water and a wait of at least 30 minutes before food or other medicines. The weight loss trial evidence belongs to the weekly injection at the 2.4 mg Wegovy dose.